Literature DB >> 9711883

Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus.

T Sakai1, B Matsuura, M Onji.   

Abstract

We investigated the serum paraoxonase (PON) activity and genotype distribution in 139 patients with non-insulin-dependent diabetes mellitus and in 240 control subjects in a Japanese population. There were no significant differences in PON genotype frequencies between the diabetic and control subjects, but the PON activity was significantly less in diabetic subjects (p<0.01). PON activity was significantly related to levels of total cholesterol and high density lipoprotein (HDL) cholesterol in the control subjects, but not in the diabetic subjects. In diabetic subjects with the genotype AA, the mean maximum intimal-medial thickness (IMT) of the carotid artery was significantly greater than in subjects with genotype AB or BB. PON may play an important role in the development of atherosclerosis associated with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711883     DOI: 10.2169/internalmedicine.37.581

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

Authors:  V H Brophy; R L Jampsa; J B Clendenning; L A McKinstry; G P Jarvik; C E Furlong
Journal:  Am J Hum Genet       Date:  2001-05-02       Impact factor: 11.025

2.  Association of PON1 gene polymorphisms with polycystic ovarian syndrome risk: a meta-analysis of case-control studies.

Authors:  D Liao; H Yu; L Han; C Zhong; X Ran; D Wang; L Mo
Journal:  J Endocrinol Invest       Date:  2018-03-15       Impact factor: 4.256

Review 3.  Human genetics of diabetic vascular complications.

Authors:  Zi-Hui Tang; Zhou Fang; Linuo Zhou
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

4.  European versus Asian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus.

Authors:  Jian-Quan Luo; Huan Ren; Mou-Ze Liu; Ping-Fei Fang; Da-Xiong Xiang
Journal:  J Cell Mol Med       Date:  2018-01-04       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.